Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 15 August 2012 Agenda Topics- Cancer Personalised Medicine
- Companion Diagnostics
- Emerging Classes of Biomarkers for MDx
- Emerging technologies in MDx
- MDx for Infectious Diseases
- Next-Generation Sequencing: Its Impact on MDx
- Oncology Biomarkers
Sponsorship and Exhibition OpportunitiesAaron Woodley, Exhibition Manager a.woodley@selectbiosciences.com +44 (0)1787 315129
|
Distinguished FacultyRobert Yamamoto, Project Manager, FLIR Mao Mao, Research Fellow, Pfizer Global Research and Development Natasha Paul, Scientific Investigator/Head, TriLink BioTechnologies Maria Paz, Managing Director, Labceutics Nicole Pamme, Senior Lecturer, University of Hull Vladimir Tolstikov, Core Director, UC Davis Genome Center Jan Weile, Project Leader, Institute for Laboratory and Transfusion Medicine at the Heart and Diabetes Centre Leanna Levine, President, ALine Inc Steve Blair, Associate Professor and Director of the Center for Microarray Technology, University of Utah Elena Schwartz, Adjunct Professor, Johns Hopkins University Mike Makrigiorgos, Professor of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School Holger Becker, CSO, Microfluidic ChipShop GmbH Simon Fredriksson, CEO, Olink Katherine Richardson, VP Research & Development, Transgenomic Paul Beresford, Vice President, Biodesix Inc
|